Skip to main content
SpringerLink
Log in

Is there a role for neurotrophins in the pathology of multiple sclerosis?

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Evidence has emerged over recent years suggesting that trophic factors such as neurotrophic cytokines and neurotrophins may play an important role in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). In mice that lack the neurotrophic cytokine ciliary neurotrophic factor (CNTF), EAE is more severe, suggesting that this molecule may normally contribute to protection of the nervous system from an inflammatory attack. The axonoprotective neurotrophin brain derived neurotrophic factor (BDNF) is not only expressed in immune cells in vitro, but also in MS lesions. Thus, infiltrating immune cells in the central nervous system (CNS) may not only be detrimental, but may also exert a protective effect, a concept referred to as “neuroprotective autoimmunity” Yet, the functional relevance of BDNF during CNS inflammation has not been definitely elucidated so far. BDNF knockout mice die prematurely and thus cannot be investigated in models of autoimmune demyelination. The analysis of recently developed conditional knockout mice with a selective suppression of BDNF production in different subsets of immune cells may improve our understanding of the role of this neurotrophin during autoimmunity of the CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aharoni R, Eilam R, Domev H, Labunskay G, Sela M, Arnon R (2005) The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc Natl Acad Sci USA 102:19045-9050

    Article  CAS  PubMed  Google Scholar 

  2. Aharoni R, Teitelbaum D, Sela M, Arnon R (1998) Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J Neuroimmunol 91:135-46

    Article  CAS  PubMed  Google Scholar 

  3. Altieri M, Marini F, Arban R, Vitulli G, Jansson BO (2004) Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res 1000:148-55

    Article  CAS  PubMed  Google Scholar 

  4. Barres BA, Burne JF, Holtmann B, Thoenen H, Sendtner M, Raff MC (1996) Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 8:146-56

    Article  CAS  Google Scholar 

  5. Besser M, Wank R (1999) Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors. J Immunol 162:6303-306

    CAS  PubMed  Google Scholar 

  6. Bravo J, Heath JK (2000) Receptor recognition by gp130 cytokines. EMBO J 19:2399-411

    Article  CAS  PubMed  Google Scholar 

  7. Butzkueven H, Emery B, Cipriani T, Marriott MP, Kilpatrick TJ (2006) Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53:696-03

    Article  PubMed  Google Scholar 

  8. Butzkueven H, Zhang JG, Soilu-Hanninen M et al. (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8:613-19

    Article  CAS  PubMed  Google Scholar 

  9. Chen M, Valenzuela RM, Dhib-Jalbut S (2003) Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor. J Neurol Sci 215:37-4

    Article  CAS  PubMed  Google Scholar 

  10. Clausen BE, Burkhardt C, Reith W, Renkawitz R, Forster I (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 8:265-77

    Article  CAS  PubMed  Google Scholar 

  11. Dittrich F, Thoenen H, Sendtner M (1994) Ciliary neurotrophic factor: pharmacokinetics and acute-phase response in rat. Ann Neurol 35:151-63

    Article  CAS  PubMed  Google Scholar 

  12. D'Souza SD, Alinauskas KA, Antel JP (1996) Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43:289-98

    Article  PubMed  Google Scholar 

  13. Emery B, Cate HS, Marriott M et al. (2006) Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc Natl Acad Sci USA 103:7859-864

    Article  CAS  PubMed  Google Scholar 

  14. Farina C, Weber MS, Meinl E, Wekerle H, Hohlfeld R (2005) Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action. Lancet Neurol 4:567-75

    Article  CAS  PubMed  Google Scholar 

  15. Giess R, Maurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P (2002) Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol 59:407-09

    Article  PubMed  Google Scholar 

  16. Giess R, Tanasescu I, Steck T, Sendtner M (1999) Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 5:581-86

    Article  CAS  PubMed  Google Scholar 

  17. Gold R, Linington C, Lassmann H (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129:1953-971

    Article  PubMed  Google Scholar 

  18. Gold R, Zielasek J, Schroder JM, Sellhaus B, Cedarbaum J, Hartung HP, Sendtner M, Toyka KV (1996) Treatment with ciliary neurotrophic factor does not improve regeneration in experimental autoimmune neuritis of the Lewis rat. Muscle Nerve 19:1177-180

    Article  CAS  PubMed  Google Scholar 

  19. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89:5547-551

    Article  CAS  PubMed  Google Scholar 

  20. Hauben E, Nevo U, Yoles E et al. (2000) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355:286-87

    Article  CAS  PubMed  Google Scholar 

  21. Hoffmann V, Pohlau D, Przuntek H, Epplen JT, Hardt C (2002) A null mutation within the ciliary neurotrophic factor (CNTF)-gene: implications for susceptibility and disease severity in patients with multiple sclerosis. Genes Immun 3:53-5

    Article  CAS  PubMed  Google Scholar 

  22. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107:161-66

    Article  CAS  PubMed  Google Scholar 

  23. Kasarskis EJ, Shefner JM, Miller R et al. (1999) A controlled trial of recombinant methionyl human BDNF in ALS. Neurology 52:1427-433

    Google Scholar 

  24. Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290-300

    Article  CAS  PubMed  Google Scholar 

  25. Kerr BJ, Patterson PH (2005) Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51:73-9

    Article  PubMed  Google Scholar 

  26. Kerschensteiner M, Gallmeier E, Behrens L (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-70

    Article  CAS  PubMed  Google Scholar 

  27. Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53:292-04

    Article  CAS  PubMed  Google Scholar 

  28. Korte M, Carroll P, Wolf E, Brem G, Thoenen H, Bonhoeffer T (1995) Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:8856-860

    Article  CAS  PubMed  Google Scholar 

  29. Kruse, N, Cetin S, Chan, A, Gold R, Luhder F (2007) Differential expression of BDNF mRNA splice variants in mouse brain and immune cells. J Neuroimmunol 182:113-19

    Article  Google Scholar 

  30. Kuhlmann T, Remington L, Cognet I et al. (2006) Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis. Am J Pathol 169:584-98

    Article  CAS  PubMed  Google Scholar 

  31. Levi-Montalcini R, Skaper S, Dal Tosco R, Petrelli L, Leon A (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 19:514-20

    Article  CAS  PubMed  Google Scholar 

  32. Lewin GR (1996) Neurotrophins and the specification of neuronal phenotype. Philos Trans R Soc Lond B Biol Sci 351:405-11

    Article  CAS  PubMed  Google Scholar 

  33. Linker RA, Maurer M, Gaupp S et al. (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8:620-24

    Article  CAS  PubMed  Google Scholar 

  34. Linker RA, Sendtner M, Gold R (2005) Mechanisms of axonal degeneration in EAE-lessons from CNTF and MHC I knockout mice. J Neurol Sci 233:167-72

    Article  CAS  PubMed  Google Scholar 

  35. Liu QR, Lu L, Zhu XG, Gong JP, Shaham Y, Uhl GR (2006) Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine Brain Res 1067:1-2

    Article  CAS  PubMed  Google Scholar 

  36. Louis JC, Magal E, Takayama S, Varon S (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259:689-92

    Article  CAS  PubMed  Google Scholar 

  37. MacDonald SC, Simcoff R, Jordan LM, Dodd JG, Cheng KW, Hochman S (2002) A population of oligodendrocytes derived from multipotent neural precursor cells expresses a cholinergic phenotype in culture and responds to ciliary neurotrophic factor. J Neurosci Res 68:255-64

    Article  CAS  PubMed  Google Scholar 

  38. Maroder M, Bellavia D, Meco D et al. (1996) Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival. J Immunol 157:2864-872

    CAS  PubMed  Google Scholar 

  39. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H (1993) Disruption of the CNTF gene results in motor neuron degeneration. Nature 365:27-2

    Article  CAS  PubMed  Google Scholar 

  40. Mayer M, Bhakoo K, Noble M (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120:143-53

    CAS  PubMed  Google Scholar 

  41. McAllister AK (2000) Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 10:963-73

    Article  CAS  PubMed  Google Scholar 

  42. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15:331-45

    Article  CAS  PubMed  Google Scholar 

  43. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-5

    Article  CAS  PubMed  Google Scholar 

  44. Nockher WA, Renz H (2006) Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 117:583-89

    Article  CAS  PubMed  Google Scholar 

  45. Ohara O, Gahara Y, Teraoka H, Kitamura T (1992) A rat brain-derived neurotrophic factor-encoding gene generates multiple transcripts through alternative use of 5' exons and polyadenylation sites. Gene 121:383-86

    Article  CAS  PubMed  Google Scholar 

  46. Ransohoff RM, Howe CL, Rodriguez M (2002) Growth factor treatment of demyelinating disease: at last, a leap into the light. Trends Immunol 23:512-16

    Article  CAS  PubMed  Google Scholar 

  47. Sauer B (2002) Cre/lox: one more step in the taming of the genome. Endocrine 19:221-28

    Article  CAS  PubMed  Google Scholar 

  48. Schuhmann B, Dietrich A, Sel S et al. (2005) A role for brain-derived neurotrophic factor in B cell development. J Neuroimmunol 163:15-3

    Article  CAS  PubMed  Google Scholar 

  49. Schuster B, Kovaleva M, Sun Y et al. (2003) Signaling of human ciliary neurotrophic factor (CNTF) revisited. The interleukin-6 receptor can serve as an alpha-receptor for CTNF. J Biol Chem 278:9528-535

    Article  CAS  PubMed  Google Scholar 

  50. Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233:163-66

    Article  CAS  PubMed  Google Scholar 

  51. Schwartz M, Kipnis (2001) Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol Med 7:252-58

    Article  CAS  PubMed  Google Scholar 

  52. Sendtner M, Stockli KA, Thoenen H (1992) Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J Cell Biol 118:139-48

    Article  CAS  PubMed  Google Scholar 

  53. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125:75-5

    Article  PubMed  Google Scholar 

  54. Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, Lubetzki C (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 22:9221-227

    CAS  PubMed  Google Scholar 

  55. Takahashi R, Yokoji H, Misawa H, Hayashi M, Hu J, Deguchi T (1994) A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet 7:79-4

    Article  CAS  PubMed  Google Scholar 

  56. Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF (1998) Leukemia inhibitory factor: part of a large ingathering family. Int Rev Immunol 16:397-26

    Article  CAS  PubMed  Google Scholar 

  57. Tennakoon DK, Mehta RS, Ortega SB, Bhoj V, Racke MK, Karandikar NJ (2006) Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis. J Immunol 176:7119-129

    CAS  PubMed  Google Scholar 

  58. Vanderlocht J, Hellings N, Hendriks JJ, Vandenabeele F, Moreels M, Buntinx M, Hoekstra D, Antel JP, Stinissen P (2006) Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factoralpha-induced oligodendrocyte apoptosis. J Neurosci Res 83:763-74

    Article  CAS  PubMed  Google Scholar 

  59. Watson FL, Heerssen HM, Moheban DB et al. (1999) Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 19:7889-900

    CAS  PubMed  Google Scholar 

  60. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61:23-2

    PubMed  Google Scholar 

  61. Ziemssen T (2004) Neuroprotection and glatiramer acetate: the possible role in the treatment of multiple sclerosis. Adv Exp Med Biol 541:111-34

    CAS  PubMed  Google Scholar 

  62. Ziemssen T, Kumpfel T, Klinkert WE, Neuhaus O, Hohlfeld R (2002) Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 125:2381-391

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Ruhr-Universität Bochum, Bochum, Germany

    Ralf Linker, De-Hyung Lee & Ines Siglienti

  2. Professor and Chair, Dept. of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum, Germany

    Ralf Gold MD

Authors
  1. Ralf Linker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. De-Hyung Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ines Siglienti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ralf Gold MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ralf Gold MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linker, R., Lee, DH., Siglienti, I. et al. Is there a role for neurotrophins in the pathology of multiple sclerosis?. J Neurol 254 (Suppl 1), I33–I40 (2007). https://doi.org/10.1007/s00415-007-1007-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-007-1007-8

Key words

Search

Navigation